CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue

Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines I...

Full description

Saved in:
Bibliographic Details
Published inEuropean Journal of Immunology Vol. 34; no. 7; pp. 1992 - 2000
Main Authors Gijsbers, Klara, Van Assche, Gert, Joossens, Sofie, Struyf, Sofie, Proost, Paul, Rutgeerts, Paul, Geboes, Karel, Van Damme, Jo
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag 01.07.2004
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines IL‐8/CXCL8 and GCP‐2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL‐8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double‐stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL‐8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP‐2, but not ENA‐78/CXCL5, nor IL‐8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL‐8 than GCP‐2. The selective GCP‐2 staining of endothelial cells at sites of ulcerations suggests that GCP‐2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA‐78) and functionally (IL‐8) related ELR+ CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy.
AbstractList Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro-inflammatory cytokines and chemokines. The intestinal expression of the CXCR1-binding chemokines IL-8/CXCL8 and GCP-2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL-8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double-stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL-8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP-2, but not ENA-78/CXCL5, nor IL-8, were highly expressed by endothelial cells in inflamed intestinal tissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL-8 than GCP-2. The selective GCP-2 staining of endothelial cells at sites of ulcerations suggests that GCP-2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA-78) and functionally (IL-8) related ELR(+) CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy.
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines IL‐8/CXCL8 and GCP‐2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL‐8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double‐stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL‐8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP‐2, but not ENA‐78/CXCL5, nor IL‐8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL‐8 than GCP‐2. The selective GCP‐2 staining of endothelial cells at sites of ulcerations suggests that GCP‐2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA‐78) and functionally (IL‐8) related ELR+ CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy.
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro-inflammatory cytokines and chemokines. The intestinal expression of the CXCR1-binding chemokines IL-8/CXCL8 and GCP-2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL-8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double-stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL-8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP-2, but not ENA-78/CXCL5, nor IL-8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL-8 than GCP-2. The selective GCP-2 staining of endothelial cells at sites of ulcerations suggests that GCP-2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA-78) and functionally (IL-8) related ELR super(+) CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy.
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro‐inflammatory cytokines and chemokines. The intestinal expression of the CXCR1‐binding chemokines IL‐8/CXCL8 and GCP‐2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL‐8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double‐stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL‐8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP‐2, but not ENA‐78/CXCL5, nor IL‐8, were highly expressed by endothelial cells in inflamed intestinaltissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL‐8 than GCP‐2. The selective GCP‐2 staining of endothelial cells at sites of ulcerations suggests that GCP‐2, despite its low production capacity in vitro , plays a role in IBD that is different from that of structurally (ENA‐78) and functionally (IL‐8) related ELR + CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy.
Author Geboes, Karel
Struyf, Sofie
Van Damme, Jo
Van Assche, Gert
Proost, Paul
Joossens, Sofie
Rutgeerts, Paul
Gijsbers, Klara
Author_xml – sequence: 1
  givenname: Klara
  surname: Gijsbers
  fullname: Gijsbers, Klara
– sequence: 2
  givenname: Gert
  surname: Van Assche
  fullname: Van Assche, Gert
– sequence: 3
  givenname: Sofie
  surname: Joossens
  fullname: Joossens, Sofie
– sequence: 4
  givenname: Sofie
  surname: Struyf
  fullname: Struyf, Sofie
– sequence: 5
  givenname: Paul
  surname: Proost
  fullname: Proost, Paul
– sequence: 6
  givenname: Paul
  surname: Rutgeerts
  fullname: Rutgeerts, Paul
– sequence: 7
  givenname: Karel
  surname: Geboes
  fullname: Geboes, Karel
– sequence: 8
  givenname: Jo
  surname: Van Damme
  fullname: Van Damme, Jo
  email: jozef.vandamme@rega.kuleuven.ac.be
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15214047$$D View this record in MEDLINE/PubMed
BookMark eNqFksFu1DAQhi1URLeFI1fkE5zS2onjxNxQVMqilUAIJG6RnYxbt4692AlLbn2EvhavwZPgZdtFQgIkS5al7_88Y88ROnDeAUJPKTmhhOSncGVOckKKnNWkeoAWtMxpxiijB2hBCGVZLmpyiI5ivCKECF6KR-hwCzHCqgX63nxuPtAfN7fKuN64C9xdwuCvjYOIjUtLWzkMcvRhxspvwOLeRJAR4kvc-41LyQAXk5Uj9Hi5Ssf6NClXNV4H30_daLzDasYWpmvfzeNO2wR_6V7EexeWrscRLCT8K-Dz5n3y5L88HMO3dYAYt559Qeku45JrNE5aPJoYJ3iMHmppIzy524_Rp9dnH5s32erd-bJ5tco6VrAqY4UUNJdVWZdM81JXShS6K2tV85JQAZJr0UmZa6I0k1woDkoIUind1TVoVRyj5ztvavDLlGpoBxM7sFY68FNsOeeMc0r_C1LBClESlsBnd-CkUmvtOphBhrm9_6UEFDugCz7GALrtzCi3TzsGaWxLSbudhTbNQrufhZTK_kjtxX_hqx2_MRbmf8Pt2dvl7-RPCKvMPw
CitedBy_id crossref_primary_10_1073_pnas_1820130116
crossref_primary_10_3389_fimmu_2014_00491
crossref_primary_10_1007_s00384_006_0135_4
crossref_primary_10_1016_j_bcp_2017_02_021
crossref_primary_10_1016_j_fct_2017_12_028
crossref_primary_10_1007_s12272_011_0111_6
crossref_primary_10_1007_s10048_014_0409_x
crossref_primary_10_3390_nu9020165
crossref_primary_10_1038_s41598_019_51328_0
crossref_primary_10_1111_j_1365_2036_2006_03016_x
crossref_primary_10_1902_jop_2008_080139
crossref_primary_10_1007_s10238_023_01152_8
crossref_primary_10_1016_j_lfs_2007_09_024
crossref_primary_10_3390_biomedicines11123229
crossref_primary_10_1111_j_1600_0765_2008_01134_x
crossref_primary_10_1016_j_ymeth_2011_09_009
crossref_primary_10_1016_j_intimp_2024_113408
crossref_primary_10_3390_ijms18081692
crossref_primary_10_1097_MPG_0b013e3182318d13
crossref_primary_10_4137_CGast_S20612
crossref_primary_10_1016_j_vetimm_2010_05_001
crossref_primary_10_1016_j_arcmed_2020_08_005
crossref_primary_10_1080_00365520802273017
crossref_primary_10_1111_ajt_12942
crossref_primary_10_1002_cam4_1147
crossref_primary_10_1002_JLB_3A0820_207R
crossref_primary_10_1016_j_febslet_2005_07_038
crossref_primary_10_1111_j_1751_2980_2008_00336_x
crossref_primary_10_1111_j_1600_0897_2008_00620_x
crossref_primary_10_4049_jimmunol_0800551
crossref_primary_10_4049_jimmunol_1500148
crossref_primary_10_1016_j_biopha_2018_10_050
crossref_primary_10_1093_ecco_jcc_jjaa236
crossref_primary_10_1111_j_1365_2249_2006_03089_x
crossref_primary_10_1093_ibd_izac233
crossref_primary_10_1016_j_anaerobe_2021_102458
crossref_primary_10_1177_0022034509347296
crossref_primary_10_1371_journal_pcbi_1004314
crossref_primary_10_1016_j_febslet_2015_10_029
crossref_primary_10_1016_j_pharmthera_2006_04_002
crossref_primary_10_3177_jnsv_55_442
crossref_primary_10_3389_fgene_2022_950136
crossref_primary_10_3390_jcm12072671
crossref_primary_10_1016_j_bcp_2007_06_034
crossref_primary_10_3389_fmed_2024_1387210
crossref_primary_10_1016_j_cytogfr_2018_10_004
crossref_primary_10_1093_jleuko_qiad097
crossref_primary_10_1073_pnas_1510084112
crossref_primary_10_1016_j_jri_2008_08_003
crossref_primary_10_1016_j_celrep_2021_110057
crossref_primary_10_3389_fcimb_2021_781022
crossref_primary_10_1097_TP_0b013e31818fe7fe
crossref_primary_10_1186_s13059_016_1084_z
crossref_primary_10_3899_jrheum_161092
Cites_doi 10.4049/jimmunol.150.3.1000
10.1021/bi961999z
10.1002/jlb.59.6.804
10.1016/S0016-5085(98)70476-7
10.4049/jimmunol.140.5.1534
10.1046/j.1365-2567.2002.01309.x
10.1002/eji.1830190706
10.1016/S0167-5699(99)01469-3
10.1046/j.1365-2796.2001.00867.x
10.1016/S0002-9440(10)63022-2
10.1038/35079107
10.1046/j.1432-1327.1998.2550067.x
10.1189/jlb.68.1.1
10.1046/j.1365-2249.2000.01364.x
10.1007/s00428-002-0684-z
10.1016/S0002-9440(10)63564-X
10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4
10.1002/path.1245
10.1016/S0002-9440(10)64034-5
10.1016/S0140-6736(02)07499-8
10.1074/jbc.M008072200
10.1023/A:1020583306627
10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S
10.1097/01.LAB.0000048719.53282.00
10.1074/jbc.270.45.27348
10.1189/jlb.72.1.9
10.1080/003655201750313397
10.1136/gut.38.2.216
10.1056/NEJM199802123380706
10.1016/S0002-9440(10)62527-8
10.1084/jem.167.2.570
10.1080/003655201750153377
10.1038/35079114
10.1182/blood.V90.3.909
10.1136/gut.47.3.404
10.1007/PL00000223
10.1016/S0140-6736(02)07284-7
10.1056/NEJMra020831
10.1136/gut.38.1.90
10.1002/1521-4141(200112)31:12<3755::AID-IMMU3755>3.0.CO;2-O
ContentType Journal Article
Copyright Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.1002/eji.200324807
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

AIDS and Cancer Research Abstracts
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1521-4141
1365-2567
EndPage 2000
ExternalDocumentID 15214047
10_1002_eji_200324807
EJI200324807
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.HR
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
UPT
V2E
VH1
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXSBR
X7M
XG1
XPP
XV2
Y6R
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
-~X
29I
2WC
36B
52R
52V
5HH
5LA
7T5
A01
A8Z
AAFWJ
AAKAS
AAMMB
ABDBF
ABXGK
ACGFO
ACGOF
ACIWK
ACMXC
ACNCT
ACUHS
ADBTR
ADZCM
AEFGJ
AEGXH
AFEBI
AGXDD
AIACR
AIAGR
AIDQK
AIDYY
AOIJS
BAWUL
C45
CAG
COF
D-6
D-7
DIK
DRMAN
E3Z
EAD
EAP
EAS
EBB
EBC
EBX
EMB
EMK
EPT
ESX
EX3
FD6
FIJ
FUBAC
GX1
H94
HZI
IH2
IHE
K48
KBYEO
MRMAN
MSMAN
MXMAN
OBC
OBS
P2Z
P4B
Q~Q
RPM
TR2
TUS
V8K
WH7
WIJ
WOQ
WOW
WXI
YF5
YFH
YOC
YUY
7X8
ID FETCH-LOGICAL-c4347-43a912a75854f65f7b93fc58b865019ea6f9caa2f0bf4a69b6eb9907bfc88efb3
IEDL.DBID DR2
ISSN 0014-2980
IngestDate Thu Jul 10 23:04:41 EDT 2025
Thu Jul 10 19:02:29 EDT 2025
Wed Feb 19 01:42:07 EST 2025
Tue Jul 01 00:48:27 EDT 2025
Thu Apr 24 23:12:33 EDT 2025
Wed Jan 22 16:20:28 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4347-43a912a75854f65f7b93fc58b865019ea6f9caa2f0bf4a69b6eb9907bfc88efb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15214047
PQID 19439504
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_66646611
proquest_miscellaneous_19439504
pubmed_primary_15214047
crossref_citationtrail_10_1002_eji_200324807
crossref_primary_10_1002_eji_200324807
wiley_primary_10_1002_eji_200324807_EJI200324807
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2004
PublicationDateYYYYMMDD 2004-07-01
PublicationDate_xml – month: 07
  year: 2004
  text: July 2004
PublicationDecade 2000
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle European Journal of Immunology
PublicationTitleAlternate Eur J Immunol
PublicationYear 2004
Publisher WILEY‐VCH Verlag
Publisher_xml – name: WILEY‐VCH Verlag
References 1998; 28
2001; 50
2000; 47
2002; 72
2000; 68
2002; 359
1998; 338
1988; 167
1999; 20
1998; 114
1988; 140
1996; 38
1998; 255
1996; 59
2003; 199
1995; 270
2001; 276
1997; 90
1994; 144
2001; 250
1997; 92
1999; 19
1997; 36
2002; 441
1993; 150
2002; 347
2002; 105
2000; 122
2003; 83
2001; 36
1996; 178
1989; 19
2001; 159
2001; 158
2001; 411
2001; 31
2003; 163
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_6_2
e_1_2_7_19_2
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_15_2
e_1_2_7_1_2
e_1_2_7_14_2
e_1_2_7_40_2
e_1_2_7_13_2
e_1_2_7_41_2
e_1_2_7_12_2
e_1_2_7_42_2
e_1_2_7_11_2
Mazzucchelli L. (e_1_2_7_20_2) 1994; 144
e_1_2_7_10_2
e_1_2_7_26_2
e_1_2_7_27_2
e_1_2_7_29_2
Stahlberg D. (e_1_2_7_28_2) 1997; 92
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_30_2
e_1_2_7_23_2
e_1_2_7_31_2
e_1_2_7_22_2
e_1_2_7_32_2
Van Damme J. (e_1_2_7_16_2) 1988; 140
e_1_2_7_21_2
e_1_2_7_33_2
e_1_2_7_34_2
e_1_2_7_35_2
e_1_2_7_36_2
e_1_2_7_37_2
e_1_2_7_38_2
e_1_2_7_39_2
Proost P. (e_1_2_7_7_2) 1993; 150
References_xml – volume: 347
  start-page: 417
  year: 2002
  end-page: 429
  article-title: Inflammatory bowel disease.
  publication-title: N. Engl. J. Med.
– volume: 47
  start-page: 404
  year: 2000
  end-page: 409
  article-title: A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.
  publication-title: Gut
– volume: 167
  start-page: 570
  year: 1988
  end-page: 581
  article-title: Macrophages secrete a novel heparin‐binding protein with inflammatory and neutrophil chemokinetic properties.
  publication-title: J. Exp. Med.
– volume: 38
  start-page: 216
  year: 1996
  end-page: 222
  article-title: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
  publication-title: Gut
– volume: 72
  start-page: 9
  year: 2002
  end-page: 18
  article-title: Role of CXCL1 in tumorigenesis of melanoma.
  publication-title: J. Leukoc. Biol.
– volume: 140
  start-page: 1534
  year: 1988
  end-page: 1541
  article-title: Separation and comparison of two monokines with lymphocyte‐activating factor activity: IL‐1 beta and hybridoma growth factor (HGF). Identification of leukocyte‐derived HGF as IL‐6.
  publication-title: J. Immunol.
– volume: 359
  start-page: 62
  year: 2002
  end-page: 69
  article-title: Crohn's disease.
  publication-title: Lancet
– volume: 441
  start-page: 500
  year: 2002
  end-page: 513
  article-title: Cytokine/chemokine messenger‐RNA expression profiles in ulcerative colitis and Crohn's disease.
  publication-title: Virchows Arch.
– volume: 68
  start-page: 1
  year: 2000
  end-page: 8
  article-title: CXC chemokines in angiogenesis.
  publication-title: J. Leukoc. Biol.
– volume: 158
  start-page: 855
  year: 2001
  end-page: 866
  article-title: The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.
  publication-title: Am. J. Pathol.
– volume: 255
  start-page: 67
  year: 1998
  end-page: 73
  article-title: Differential usage of the CXC chemokine receptors 1 and 2 by interleukin‐8, granulocyte chemotactic protein‐2 and epithelial‐cell‐derived neutrophil attractant‐78.
  publication-title: Eur. J. Biochem.
– volume: 411
  start-page: 603
  year: 2001
  end-page: 606
  article-title: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
  publication-title: Nature
– volume: 163
  start-page: 2065
  year: 2003
  end-page: 2075
  article-title: PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.
  publication-title: Am. J. Pathol.
– volume: 36
  start-page: 2716
  year: 1997
  end-page: 2723
  article-title: Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties.
  publication-title: Biochemistry
– volume: 19
  start-page: 1189
  year: 1989
  end-page: 1194
  article-title: The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte‐derived interleukin 8.
  publication-title: Eur. J. Immunol.
– volume: 38
  start-page: 90
  year: 1996
  end-page: 98
  article-title: Interleukin 8: cells of origin in inflammatory bowel disease.
  publication-title: Gut
– volume: 150
  start-page: 1000
  year: 1993
  end-page: 1010
  article-title: Identification of a novel granulocyte chemotactic protein (GCP‐2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP‐10, and IL‐8.
  publication-title: J. Immunol.
– volume: 50
  start-page: 491
  year: 2001
  end-page: 495
  article-title: Tissue cytokine and chemokine expression in inflammatory bowel disease.
  publication-title: Inflamm. Res.
– volume: 31
  start-page: 3755
  year: 2001
  end-page: 3762
  article-title: Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis.
  publication-title: Eur. J. Immunol.
– volume: 199
  start-page: 28
  year: 2003
  end-page: 35
  article-title: Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
  publication-title: J. Pathol.
– volume: 36
  start-page: 854
  year: 2001
  end-page: 864
  article-title: Coordinateupregulation of interleukin‐8 and growth‐related gene product‐alpha is present in the colonic mucosa of inflammatory bowel.
  publication-title: Scand. J. Gastroenterol.
– volume: 159
  start-page: 1405
  year: 2001
  end-page: 1414
  article-title: Tumor angiogenesis induced by granulocyte chemotactic protein‐2 as a countercurrent principle.
  publication-title: Am. J. Pathol.
– volume: 20
  start-page: 254
  year: 1999
  end-page: 257
  article-title: The chemokine system: redundancy for robust outputs.
  publication-title: Immunol. Today
– volume: 92
  start-page: 283
  year: 1997
  end-page: 288
  article-title: Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histologial assessment and Tc‐99 m‐HMPAO labeled leukocyte scan.
  publication-title: Am. J. Gastroenterol.
– volume: 338
  start-page: 436
  year: 1998
  end-page: 445
  article-title: Chemokines–chemotactic cytokines that mediate inflammation.
  publication-title: N. Engl. J. Med.
– volume: 276
  start-page: 4812
  year: 2001
  end-page: 4818
  article-title: Nod2, a Nod1/Apaf‐1 family member that is restricted to monocytes and activates NF‐kappaB.
  publication-title: J. Biol. Chem.
– volume: 114
  start-page: 262
  year: 1998
  end-page: 267
  article-title: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.
  publication-title: Gastroenterology
– volume: 250
  start-page: 91
  year: 2001
  end-page: 104
  article-title: Chemokines in pathology and medicine.
  publication-title: J. Intern. Med.
– volume: 122
  start-page: 180
  year: 2000
  end-page: 185
  article-title: Enhanced production of IL‐8 in chronic but not in early ileal lesions of Crohn's disease (CD).
  publication-title: Clin. Exp. Immunol.
– volume: 411
  start-page: 599
  year: 2001
  end-page: 603
  article-title: Association of NOD2 leucine‐rich repeat variants with susceptibility to Crohn's disease.
  publication-title: Nature
– volume: 28
  start-page: 164
  year: 1998
  end-page: 170
  article-title: Granulocyte chemotactic protein 2 acts via both IL‐8 receptors, CXCR1 and CXCR2.
  publication-title: Eur. J. Immunol.
– volume: 19
  start-page: 266
  year: 1999
  end-page: 272
  article-title: Chemokines in the inflammatory bowel diseases.
  publication-title: J. Clin. Immunol.
– volume: 90
  start-page: 909
  year: 1997
  end-page: 928
  article-title: Chemokines.
  publication-title: Blood
– volume: 36
  start-page: 515
  year: 2001
  end-page: 520
  article-title: Increased serum levels of eotaxin in patients with inflammatory bowel disease.
  publication-title: Scand. J. Gastroenterol.
– volume: 59
  start-page: 804
  year: 1996
  end-page: 812
  article-title: Enhanced expression and production of monocyte chemoattractant protein‐1 in inflammatory bowel disease mucosa.
  publication-title: J. Leukoc. Biol.
– volume: 144
  start-page: 997
  year: 1994
  end-page: 1007
  article-title: Expression of interleukin‐8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
  publication-title: Am. J. Pathol.
– volume: 359
  start-page: 331
  year: 2002
  end-page: 340
  article-title: Ulcerative colitis.
  publication-title: Lancet
– volume: 178
  start-page: 201
  year: 1996
  end-page: 206
  article-title: Differential in situ expression of the genes encoding the chemokines MCP‐1 and RANTES in human inflammatory bowel disease.
  publication-title: J. Pathol.
– volume: 159
  start-page: 1751
  year: 2001
  end-page: 1761
  article-title: Expression of the T cell chemoattractant chemokine lymphotactin in Crohn's disease.
  publication-title: Am. J. Pathol.
– volume: 83
  start-page: 23
  year: 2003
  end-page: 34
  article-title: The CXC chemokine GCP‐2/CXCL6 is predominantly induced in mesenchymal cells byinterleukin‐1beta and is down‐regulated by interferon‐gamma: comparison with interleukin‐8/CXCL8.
  publication-title: Lab. Invest.
– volume: 270
  start-page: 27348
  year: 1995
  end-page: 27357
  article-title: The functional role of the ELR motif in CXC chemokine‐mediated angiogenesis.
  publication-title: J. Biol. Chem.
– volume: 105
  start-page: 137
  year: 2002
  end-page: 143
  article-title: Role of chemokines and chemokine receptors in the gastrointestinal tract.
  publication-title: Immunology
– volume: 150
  start-page: 1000
  year: 1993
  ident: e_1_2_7_7_2
  article-title: Identification of a novel granulocyte chemotactic protein (GCP‐2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP‐10, and IL‐8.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.150.3.1000
– ident: e_1_2_7_8_2
  doi: 10.1021/bi961999z
– ident: e_1_2_7_34_2
  doi: 10.1002/jlb.59.6.804
– ident: e_1_2_7_41_2
  doi: 10.1016/S0016-5085(98)70476-7
– volume: 140
  start-page: 1534
  year: 1988
  ident: e_1_2_7_16_2
  article-title: Separation and comparison of two monokines with lymphocyte‐activating factor activity: IL‐1 beta and hybridoma growth factor (HGF). Identification of leukocyte‐derived HGF as IL‐6.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.140.5.1534
– ident: e_1_2_7_18_2
  doi: 10.1046/j.1365-2567.2002.01309.x
– ident: e_1_2_7_17_2
  doi: 10.1002/eji.1830190706
– ident: e_1_2_7_31_2
  doi: 10.1016/S0167-5699(99)01469-3
– ident: e_1_2_7_5_2
  doi: 10.1046/j.1365-2796.2001.00867.x
– ident: e_1_2_7_24_2
  doi: 10.1016/S0002-9440(10)63022-2
– ident: e_1_2_7_35_2
  doi: 10.1038/35079107
– ident: e_1_2_7_27_2
  doi: 10.1046/j.1432-1327.1998.2550067.x
– ident: e_1_2_7_3_2
  doi: 10.1189/jlb.68.1.1
– ident: e_1_2_7_29_2
  doi: 10.1046/j.1365-2249.2000.01364.x
– ident: e_1_2_7_15_2
  doi: 10.1007/s00428-002-0684-z
– ident: e_1_2_7_40_2
  doi: 10.1016/S0002-9440(10)63564-X
– ident: e_1_2_7_21_2
  doi: 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4
– ident: e_1_2_7_14_2
  doi: 10.1002/path.1245
– ident: e_1_2_7_23_2
  doi: 10.1016/S0002-9440(10)64034-5
– ident: e_1_2_7_10_2
  doi: 10.1016/S0140-6736(02)07499-8
– ident: e_1_2_7_37_2
  doi: 10.1074/jbc.M008072200
– ident: e_1_2_7_12_2
  doi: 10.1023/A:1020583306627
– ident: e_1_2_7_9_2
  doi: 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S
– ident: e_1_2_7_32_2
  doi: 10.1097/01.LAB.0000048719.53282.00
– ident: e_1_2_7_6_2
  doi: 10.1074/jbc.270.45.27348
– ident: e_1_2_7_4_2
  doi: 10.1189/jlb.72.1.9
– ident: e_1_2_7_19_2
  doi: 10.1080/003655201750313397
– ident: e_1_2_7_25_2
  doi: 10.1136/gut.38.2.216
– ident: e_1_2_7_2_2
  doi: 10.1056/NEJM199802123380706
– ident: e_1_2_7_30_2
  doi: 10.1016/S0002-9440(10)62527-8
– ident: e_1_2_7_38_2
  doi: 10.1084/jem.167.2.570
– ident: e_1_2_7_26_2
  doi: 10.1080/003655201750153377
– ident: e_1_2_7_36_2
  doi: 10.1038/35079114
– ident: e_1_2_7_1_2
  doi: 10.1182/blood.V90.3.909
– ident: e_1_2_7_42_2
  doi: 10.1136/gut.47.3.404
– ident: e_1_2_7_22_2
  doi: 10.1007/PL00000223
– ident: e_1_2_7_11_2
  doi: 10.1016/S0140-6736(02)07284-7
– ident: e_1_2_7_13_2
  doi: 10.1056/NEJMra020831
– volume: 92
  start-page: 283
  year: 1997
  ident: e_1_2_7_28_2
  article-title: Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histologial assessment and Tc‐99 m‐HMPAO labeled leukocyte scan.
  publication-title: Am. J. Gastroenterol.
– ident: e_1_2_7_33_2
  doi: 10.1136/gut.38.1.90
– volume: 144
  start-page: 997
  year: 1994
  ident: e_1_2_7_20_2
  article-title: Expression of interleukin‐8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
  publication-title: Am. J. Pathol.
– ident: e_1_2_7_39_2
  doi: 10.1002/1521-4141(200112)31:12<3755::AID-IMMU3755>3.0.CO;2-O
SSID ssj0009659
ssj0013055
Score 2.0374753
Snippet Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1992
SubjectTerms Angiogenesis
Chemokine CXCL6
Chemokines, CXC - biosynthesis
Chemokines, CXC - metabolism
Crohn Disease - blood
Crohn Disease - metabolism
Crohn Disease - pathology
Crohn's disease
Down-Regulation
Endothelial Cells - metabolism
Enzyme-Linked Immunosorbent Assay
Granulocyte chemotactic protein‐2
Humans
Immunohistochemistry
Inflammation - blood
Inflammation - metabolism
Inflammatory bowel diseases
Intercellular Signaling Peptides and Proteins - biosynthesis
Intercellular Signaling Peptides and Proteins - metabolism
Interleukin-8 - biosynthesis
Interleukin-8 - metabolism
Interleukin‐8
Intestines - metabolism
Intestines - pathology
Leukocytes - metabolism
Receptors, Interleukin-8A - biosynthesis
Receptors, Interleukin-8A - metabolism
Title CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.200324807
https://www.ncbi.nlm.nih.gov/pubmed/15214047
https://www.proquest.com/docview/19439504
https://www.proquest.com/docview/66646611
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQJRAXHuW1PH1AcCHdPBzH4YailrZqEaqotLfgcWxYdptUm6xgOfET-Fv8DX4JYzu7qwUVCRHlEske2_J4_Dkz_oaQp6ICyLWCgGdGBQxMFuQKwiBTObN-oYg7surjN3z_lB2O0lGf59TehfH8EKsfbnZlOHttF7iEdrgmDdWfxo7OM7aXotEG23gtC4pO1vRRlizPW2IWxLkIe45NrD_cqL25J_0BNDdxq9t49q6T98su-3iTyc68gx319Tc2x_8Y0w1yrQel9JXXopvkkq63yWWfpnKxTa4c9w74W-RHMSpOop_fvsPYXYehOOdnzcTGztNxja9BDTtznnsKzWc9pb0HqH1JKzzwY82Z_mBThumKHhzhpxiiyCNBzz31LKoJhQWd6vmkUYvOiy1mzcf6ebuURWVd0dYl8EFbTV8Xb1FO7ORwqr_0ob31ukPYlqXFQGtmh9k5XbtNTvd23xX7QZ8NIlAsYVnAEplHsbTnG2Z4ajLIE6NSAQJBZpRryU2upIxNCIZJngPXgFttBkYJoQ0kd8hW3dT6HqFSykxmokrwYVHEgQuuDR5ck1SISrABebHUh1L1VOk2Y8e09CTPcYkTVa4makCerYqfe46Qiwo-WSpXiavYumZkrZt5W0Y5AsM0ZBeXwGMmQywVDchdr5XrphCBsZCh9NDp1t_7UO4eHqw-7v97lQfkqg9eshHLD8lWN5vrR4jLOnjsFt8vt6k0qw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELagiMeFRykQXvUBwYVt9uH12tzQqiUpSYWqVsptZXttCEl3qzwE4cRP4G_xN_gljO1NQkBFQqz2Yske2_KMPeMZf4PQM1ZKybWSAc2MCog0WcCVDINMcWL9QhF1YNX9I9o5JYeDdPDLK36PD7G6cLOS4fZrK-D2Qrq9Rg3VH4cOzzO2r6Ivoys2q7czqo7XAFIWLs_vxSSIOQsblE0g0N5ovnkq_aFqbmqu7ug5uIXEctA-4mS0N5_JPfXlNzzH_5nVbXSz0Uvxa89Id9AlXW2jqz5T5WIbXes3Pvi76Hs-yI-jH1-_yaF7EYNh2c_qkQ2fx8MKfgNMduac91jWn_QYN06g6Stcgs0PLSf6vc0apkvc7UGRtYFkj-Fzjz4LnILlAo_1fFSrxcyTzSf1h-rFdEkLi6rEU5fDB7Zr_CZ_B3RiR4di_bmJ7q3WA4K-LDIGbGh2mjPHbjvo9GD_JO8ETUKIQJGEZAFJBI9iYU0cYmhqMskTo1ImGeiZEdeCGq6EiE0oDRGUS6olnLaZNIoxbWRyD21VdaUfICyEyETGygQ-EkVUUka1Ads1SRkrGWmhl0uGKFSDlm6TdowLj_McF7BQxWqhWuj5qvq5hwm5qOLukrsKEGTrnRGVrufTIuKgG6YhubgGWJoE1Kmohe57tlx3BUoYCQlQDx1z_X0Mxf5hd1V4-O9NdtH1zkm_V_S6R28foRs-lskGMD9GW7PJXD8BNW0mnzpJ_AnbCjjG
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZgiIkXLuNWbvMDghey5uI4Dm8oW1lHN00Tk_qW2Y7NunZJ1aaC8sRP4G_xN_glHNtpq4KGhIjyEsk-tuXP9jk5x99B6CUrhEiVFB5NtPSI0ImXSuF7iUyJ8QsF1JJVHx7R_VNy0I_7TZ5TcxfG8UMsf7iZlWH3a7PAx4Vur0hD1cXA0nmG5lL0dXSDUJ8ZWO-erPijDFue24qJF6bMb0g2QUB7rfr6ofSHprmuuNqTp3MHnS367AJOhjuzWuzIr7_ROf7HoO6i241Wit85GN1D11S5hW66PJXzLbR52Hjg76MfWT87CX5--y4G9j4Mhkm_rIYmeB4PSng1QOzSuu6xqD6rEW5cQNO3uACLH2pO1CeTM0wVuNuDT9YGkT2Gx457FnCCxRyP1GxYyXntxGaT6rx8PV3Iwrws8NRm8IHNGr_PjkFOaOVQrL40sb3lqkPQluHFgO3MDLO2YHuATjt7H7N9r0kH4UkSkcQjEU-DkBsDh2ga60SkkZYxEwy0zCBVnOpUch5qX2jCaSqoEnDWJkJLxpQW0UO0UValeoww5zzhCSsieEgQUEEZVRos1yhmrGCkhd4s8JDLhivdpOwY5Y7lOcxhovLlRLXQq2XxsSMJuarg9gJcOSxj45vhpapm0zxIQTOMfXJ1CbAzCShTQQs9cqhcNQUqGPEJSPcttv7eh3zvoLv8ePLvVbbR5vFuJ-91jz48RbdcIJOJXn6GNurJTD0HHa0WL-w6_AUqJDd-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CXCR1%E2%80%90binding+chemokines+in+inflammatory+bowel+diseases%3A+down%E2%80%90regulated+IL%E2%80%908%2FCXCL8+production+by+leukocytes+in+Crohn%27s+disease+and+selective+GCP%E2%80%902%2FCXCL6+expression+in+inflamed+intestinal+tissue&rft.jtitle=European+journal+of+immunology&rft.au=Gijsbers%2C+Klara&rft.au=Van+Assche%2C+Gert&rft.au=Joossens%2C+Sofie&rft.au=Struyf%2C+Sofie&rft.date=2004-07-01&rft.issn=0014-2980&rft.eissn=1521-4141&rft.volume=34&rft.issue=7&rft.spage=1992&rft.epage=2000&rft_id=info:doi/10.1002%2Feji.200324807&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_eji_200324807
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon